Search Results

Medical and consumer genetics testing innovator and Imperial College London spin-out, DnaNudge, today announces that it has received approval from Ghana’s Food and Drugs Authority (FDA) to deliver its breakthrough four-in-one, respiratory viruses test for clinical deployment both inside and outside labs in the West African country.

First handheld polymerase chain reaction (PCR) genomic diagnostic cartridge and chip to transform real-time decision support for healthy lifestyle choices and potential to transform the diagnosis of infections and cancer risk based on personal genomics at point-of-decision NantNudge close multi-million dollar deal with Imperial College spin-off, DnaNudge First soft launch in Los Angeles at the Inspirational Women Forum conference on November 7, 2023.

SMITM CAPITAL MARKETS LTD, has announced a significant agreement with Mid-Atlantic BioTherapeutics, Inc. (MABT), a clinical-stage ready US biopharmaceutical company.

Specac, Ltd announced today the acquisition of Harrick Scientific, Inc.

Meihua International Medical Technologies Co., Ltd., a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, announced that its board of directors has approved and authorized a share repurchase program of up to $3 million of the Company’s outstanding ordinary shares.

This announcement summarizes Bioretec Ltd’s business review for January-March 2024.

ImmunoPrecise Antibodies Ltd., a leader in AI-driven biotherapeutic research and technology, announces that its subsidiary, BioStrand, has been honored with the prestigious 2024 Impact Award, sponsored by InterSystems.

Vanda Pharmaceuticals Inc. confirmed that it has received an unsolicited, non-binding indication of interest from Cycle Group Holdings Ltd. to acquire the Company for $8.00 per share in cash.